263 related articles for article (PubMed ID: 2522917)
41. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
Walling JM; Stratford IJ; Adams GE; Silver AR; Ahmed I; Jenkins TC; Fielden EM
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
[TBL] [Abstract][Full Text] [Related]
42. Combined radiation-protective and radiation-sensitizing agents. III: Radiosensitization by misonidazole as a function of concentrations of endogenous glutathione or exogenous thiols.
Koch CJ; Stobbe CC; Baer KA
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1151-5. PubMed ID: 3744933
[TBL] [Abstract][Full Text] [Related]
43. Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
Hofer KG; Lakkis M; Hofer MG
Cancer; 1989 Apr; 63(8):1501-8. PubMed ID: 2924258
[TBL] [Abstract][Full Text] [Related]
44. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
Brown DM; Yu NY; Brown JM; Lee WW
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
[TBL] [Abstract][Full Text] [Related]
45. [Development of new hypoxic cell radiosensitizer in Japan].
Mori T; Murayama C
Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
[TBL] [Abstract][Full Text] [Related]
46. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer.
Hori H; Murayama C; Mori T; Shibamoto Y; Abe M; Onoyama Y; Inayama S
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1029-32. PubMed ID: 2703381
[TBL] [Abstract][Full Text] [Related]
47. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system.
Honess DJ; Wasserman TH; Workman P; Ward R; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):671-5. PubMed ID: 2971028
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
Rojas A; Smith KA; Soranson JA; Minchinton AI; Middleton RW; Denekamp J
Radiother Oncol; 1984 Dec; 2(4):325-32. PubMed ID: 6522642
[TBL] [Abstract][Full Text] [Related]
49. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Hinchliffe M; McNally NJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
[TBL] [Abstract][Full Text] [Related]
50. Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.
Denekamp J; Michael BD; Minchinton AI; Smithen CE; Stewart FA; Stratford MR; Terry NH
Br J Cancer; 1982 Feb; 45(2):247-55. PubMed ID: 7059473
[TBL] [Abstract][Full Text] [Related]
51. A rapid-mix study on the effect of lipophilicity of nitroimidazoles on the radiosensitization of mammalian cells in vitro.
Watts ME; Hodgkiss RJ; Jones NR; Sehmi DS; Woodcock M
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Mar; 43(3):329-36. PubMed ID: 6601082
[TBL] [Abstract][Full Text] [Related]
52. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
Astor M; Hall EJ
Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
[TBL] [Abstract][Full Text] [Related]
53. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
54. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
Austen KR; Jenner TJ; O'Neill P; Fielden EM
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
56. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
Shibamoto Y; Streffer C; Sasai K; Oya N; Abe M
Int J Radiat Biol; 1992 Apr; 61(4):473-8. PubMed ID: 1349329
[TBL] [Abstract][Full Text] [Related]
57. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Newman HF; Ward R; Workman P; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1073-83. PubMed ID: 2972667
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of hypoxic cell radiosensitization and the development of new sensitizers.
Stratford IJ
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):391-8. PubMed ID: 7050037
[TBL] [Abstract][Full Text] [Related]
59. The effect on the Km for radiosensitization at 0 degree C of thiol depletion by diethylmaleate pretreatment: quantitative differences found using the radiation sensitizing agent misonidazole or oxygen.
Koch CJ; Stobbe CC; Bump EA
Radiat Res; 1984 Apr; 98(1):141-53. PubMed ID: 6718689
[TBL] [Abstract][Full Text] [Related]
60. A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokinetics.
Newman HF; Bleehen NM; Workman P
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1113-6. PubMed ID: 2943709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
